APA (7 ম সংস্করণ) উদ্ধৃতি

Bafadhel, M., Sing, D., Jenkins, C., Peterson, S., Bengtsson, T., & Fageras, M. (2018). Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS). European Respiratory Society.

শিকাগো স্টাইল (17 তম সংস্করণ) উদ্ধৃতি

Bafadhel, M., D. Sing, C. Jenkins, S. Peterson, T. Bengtsson, এবং M. Fageras. Late Breaking Abstract - Protection by Budesonide Against Clinically Important Deteriorations (CID) in Patients with COPD Is Dependent on Blood Eosinophil Counts (EOS). European Respiratory Society, 2018.

M.L.A (9 ম সংস্করণ) উদ্ধৃতি

Bafadhel, M., et al. Late Breaking Abstract - Protection by Budesonide Against Clinically Important Deteriorations (CID) in Patients with COPD Is Dependent on Blood Eosinophil Counts (EOS). European Respiratory Society, 2018.

সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.